These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
401 related articles for article (PubMed ID: 23046292)
21. Enhancing in vitro dissolution and in vivo bioavailability of fenofibrate by solid self-emulsifying matrix combined with SBA-15 mesoporous silica. Quan G; Wu Q; Zhang X; Zhan Z; Zhou C; Chen B; Zhang Z; Li G; Pan X; Wu C Colloids Surf B Biointerfaces; 2016 May; 141():476-482. PubMed ID: 26896653 [TBL] [Abstract][Full Text] [Related]
23. Combined effects of the drug distribution and mucus diffusion properties of self-microemulsifying drug delivery systems on the oral absorption of fenofibrate. Sunazuka Y; Ueda K; Higashi K; Tanaka Y; Moribe K Int J Pharm; 2018 Jul; 546(1-2):263-271. PubMed ID: 29763688 [TBL] [Abstract][Full Text] [Related]
24. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) of darunavir for improved dissolution and oral bioavailability: In vitro and in vivo evaluation. Inugala S; Eedara BB; Sunkavalli S; Dhurke R; Kandadi P; Jukanti R; Bandari S Eur J Pharm Sci; 2015 Jul; 74():1-10. PubMed ID: 25845633 [TBL] [Abstract][Full Text] [Related]
25. Effects of solid carriers on the crystalline properties, dissolution and bioavailability of flurbiprofen in solid self-nanoemulsifying drug delivery system (solid SNEDDS). Kang JH; Oh DH; Oh YK; Yong CS; Choi HG Eur J Pharm Biopharm; 2012 Feb; 80(2):289-97. PubMed ID: 22119666 [TBL] [Abstract][Full Text] [Related]
26. In situ formation of nanocrystals from a self-microemulsifying drug delivery system to enhance oral bioavailability of fenofibrate. Lin YM; Wu JY; Chen YC; Su YD; Ke WT; Ho HO; Sheu MT Int J Nanomedicine; 2011; 6():2445-57. PubMed ID: 22072880 [TBL] [Abstract][Full Text] [Related]
27. Lipidic dispersion to reduce food dependent oral bioavailability of fenofibrate: In vitro, in vivo and in silico assessments. O'Shea JP; Faisal W; Ruane-O'Hora T; Devine KJ; Kostewicz ES; O'Driscoll CM; Griffin BT Eur J Pharm Biopharm; 2015 Oct; 96():207-16. PubMed ID: 26215636 [TBL] [Abstract][Full Text] [Related]
28. Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. Shen H; Zhong M J Pharm Pharmacol; 2006 Sep; 58(9):1183-91. PubMed ID: 16945176 [TBL] [Abstract][Full Text] [Related]
29. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Yeom DW; Son HY; Kim JH; Kim SR; Lee SG; Song SH; Chae BR; Choi YW Int J Pharm; 2016 Jun; 506(1-2):302-11. PubMed ID: 27125455 [TBL] [Abstract][Full Text] [Related]
30. Effect of magnesium carbonate on the solubility, dissolution and oral bioavailability of fenofibric acid powder as an alkalising solubilizer. Kim KS; Kim JH; Jin SG; Kim DW; Kim DS; Kim JO; Yong CS; Cho KH; Li DX; Woo JS; Choi HG Arch Pharm Res; 2016 Apr; 39(4):531-538. PubMed ID: 26992922 [TBL] [Abstract][Full Text] [Related]
31. Self-microemulsifying drug delivery system (SMEDDS) for improved oral delivery and photostability of methotrexate. Kim DS; Cho JH; Park JH; Kim JS; Song ES; Kwon J; Giri BR; Jin SG; Kim KS; Choi HG; Kim DW Int J Nanomedicine; 2019; 14():4949-4960. PubMed ID: 31308665 [No Abstract] [Full Text] [Related]
32. A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats. Wu L; Qiao Y; Wang L; Guo J; Wang G; He W; Yin L; Zhao J AAPS PharmSciTech; 2015 Oct; 16(5):1051-8. PubMed ID: 25652729 [TBL] [Abstract][Full Text] [Related]
33. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach. Fei Y; Kostewicz ES; Sheu MT; Dressman JB Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116 [TBL] [Abstract][Full Text] [Related]
34. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing. Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985 [TBL] [Abstract][Full Text] [Related]
35. Solid self-microemulsifying drug delivery system of Sophoraflavanone G: Prescription optimization and pharmacokinetic evaluation. Yang Z; Wang Y; Cheng J; Shan B; Wang Y; Wang R; Hou L Eur J Pharm Sci; 2019 Aug; 136():104953. PubMed ID: 31175944 [TBL] [Abstract][Full Text] [Related]
36. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Setthacheewakul S; Mahattanadul S; Phadoongsombut N; Pichayakorn W; Wiwattanapatapee R Eur J Pharm Biopharm; 2010 Nov; 76(3):475-85. PubMed ID: 20659556 [TBL] [Abstract][Full Text] [Related]
37. Bioavailability of seocalcitol II: development and characterisation of self-microemulsifying drug delivery systems (SMEDDS) for oral administration containing medium and long chain triglycerides. Grove M; Müllertz A; Nielsen JL; Pedersen GP Eur J Pharm Sci; 2006 Jun; 28(3):233-42. PubMed ID: 16650738 [TBL] [Abstract][Full Text] [Related]
38. Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug. Bandivadeka MM; Pancholi SS; Kaul-Ghanekar R; Choudhari A; Koppikar S Drug Dev Ind Pharm; 2012 Jul; 38(7):883-92. PubMed ID: 22087760 [TBL] [Abstract][Full Text] [Related]
39. Quality-by-design based development of a self-microemulsifying drug delivery system to reduce the effect of food on Nelfinavir mesylate. Kamboj S; Rana V Int J Pharm; 2016 Mar; 501(1-2):311-25. PubMed ID: 26854426 [TBL] [Abstract][Full Text] [Related]
40. Enhanced oral bioavailability of fenofibrate using polymeric nanoparticulated systems: physicochemical characterization and in vivo investigation. Yousaf AM; Kim DW; Oh YK; Yong CS; Kim JO; Choi HG Int J Nanomedicine; 2015; 10():1819-30. PubMed ID: 25784807 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]